Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/1998
03/26/1998WO1998012333A1 Immunogenic peptides of foot-and-mouth disease viruses
03/26/1998WO1998012332A1 Compositions and methods for treating intracellular diseases
03/26/1998WO1998012331A1 Novel polypeptide originating in hemophilus paragallinarum and process for producing the same
03/26/1998WO1998012330A1 Mammalian cytokine, related reagents
03/26/1998WO1998012329A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998WO1998012325A1 Human gtp binding protein gamma-3
03/26/1998WO1998012221A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
03/26/1998WO1998012220A2 Novel tumor proteins
03/26/1998WO1998011920A2 Method of capture of a bioactive agent by a nanoerythrosome preparation
03/26/1998WO1998011919A2 Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof
03/26/1998WO1998011918A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation
03/26/1998WO1998011917A1 Hiv-1 therapy with il-2 and anti-tnf antibody
03/26/1998WO1998011916A1 Viral defective interfering particles and uses thereof
03/26/1998WO1998011915A1 Strain selection of pneumococcal surface proteins
03/26/1998WO1998011914A1 Targeting antigens to the mhc class i processing pathway with anthrax toxin fusion protein
03/26/1998WO1998011778A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases
03/26/1998WO1998007874A3 New systems for regulating genetic expression
03/26/1998WO1998003653A3 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor
03/26/1998WO1997048370A3 Vaccines comprising synthetic genes
03/26/1998WO1997047740A3 VACCINE CONTAINING A PEROXIREDOXIN AND/OR A β-TUBULIN
03/26/1998WO1997040063A3 Pathogenic escherichia coli associated protein espa
03/26/1998DE19704301C1 Human endoglin gene promoter
03/26/1998DE19639103A1 DNA construct with inhibitory mutation and corrective mutation
03/26/1998CA2267343A1 Strain selection of pneumococcal surface proteins
03/26/1998CA2266684A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation
03/26/1998CA2266656A1 Compositions and methods for treating intracellular diseases
03/26/1998CA2266388A1 Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof
03/26/1998CA2266341A1 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998CA2266339A1 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998CA2265852A1 Targeting antigens to the mhc class i processing pathway with anthrax toxin fusion protein
03/26/1998CA2265518A1 Immunogenic peptides of foot-and-mouth disease viruses
03/26/1998CA2264542A1 Human gtp binding protein gamma-3
03/26/1998CA2263818A1 Novel tumor proteins
03/26/1998CA2236165A1 Novel polypeptide from haemophilus paragallinarum and process for preparing the same
03/25/1998EP0830602A1 Expression system for non-secretor genes
03/25/1998EP0830456A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
03/25/1998EP0830455A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
03/25/1998EP0830452A1 Immune-evading proteins
03/25/1998EP0830450A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
03/25/1998EP0830380A1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof
03/25/1998EP0830143A1 Use of leukemia inhibitory factor and endothelin antagonists
03/25/1998EP0830142A1 Viral agent associated with mystery swine disease
03/25/1998EP0830141A1 Improved virus vaccines
03/25/1998EP0830140A1 A pluripotent vaccine against enveloped viruses
03/25/1998EP0830139A1 Modified myelin protein molecules
03/25/1998EP0714306B1 Inactivated respiratory syncytial viral vaccines
03/25/1998EP0679094B1 Compounds for targeting
03/25/1998CN1177302A Lymphotoxin-
03/25/1998CN1176827A Method for preparing freeze-dried live vaccine for animal use
03/24/1998US5731427 Nucleic acids encoding a gap-associated protein
03/24/1998US5731200 Isolated nucleic acid encoding receptor-like TGF-β1 binding protein
03/24/1998US5731196 Salmonella virulence genes
03/24/1998US5731188 Vaccine
03/24/1998US5731187 Process for preparing hepatitis A (HAV) antigens and vaccines
03/24/1998US5731170 DNA encoding a growth factor specific for epithelial cells
03/24/1998US5731168 Method for making heteromultimeric polypeptides
03/24/1998US5731151 Tuberculosis vaccine
03/24/1998US5731149 Antibiotic cryptdin peptides and methods of their use
03/24/1998US5730990 Non-antigenic amine derived polymers and polymer conjugates
03/24/1998US5730989 Oral vaccine against gram negative bacterial infection
03/24/1998US5730984 Vaccine against helminth infection comprising Sm-14 fatty acid binding protein of Schistosoma mansoni
03/24/1998US5730982 Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof
03/24/1998US5730981 Monoclonal anti-ganglioside antibody and its preparation
03/24/1998US5730980 Methods and compositions for ameliorating the symptoms of sepsis
03/24/1998US5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function
03/24/1998CA2211008A1 Nucleic acid constructs containing hybrid promoters for use in gene therapy
03/24/1998CA1339775C Antibody 0.5b to hiv-i gp 120 modified with toxic substance
03/24/1998CA1339774C Recombinant marek's disease virus, process for preparing the same and vaccine containing the same
03/24/1998CA1339772C Method for separating long-chain nucleic acid
03/24/1998CA1339770C Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
03/23/1998CA2196502A1 Compositions and methods for treatment of streptococcus pneumoniae infection
03/19/1998WO1998011435A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
03/19/1998WO1998011245A1 Sustained delivery device and methods of making and using the same
03/19/1998WO1998011236A1 Aspartic protease
03/19/1998WO1998011229A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
03/19/1998WO1998011225A2 A novel haemopoietin receptor and genetic sequences encoding same
03/19/1998WO1998011223A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998WO1998011202A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids
03/19/1998WO1998011133A1 New picornaviruses, vaccines and diagnostic kits
03/19/1998WO1998011117A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/19/1998WO1998011116A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998WO1998010795A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same
03/19/1998WO1998010794A2 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
03/19/1998WO1998010792A1 Immune direction therapy
03/19/1998WO1998010791A1 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
03/19/1998WO1998010790A1 Papillomavirus vaccine formulation
03/19/1998WO1998010789A1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof
03/19/1998WO1998010788A1 Staphylococcus aureus antigen
03/19/1998WO1998010787A2 Pharmaceutical compositions for the treatment of immune disorders
03/19/1998WO1998010777A1 Nucleosome-based anti-tumor compositions
03/19/1998WO1998010776A1 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
03/19/1998WO1998010749A1 Protein-lipid vesicles and autogenous vaccine comprising the same
03/19/1998WO1998010748A1 Liposomes
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998DE19638044A1 Immunogene Peptide von Maul- und Klauenseuchen-Viren Immunogenic peptides of foot-and-mouth disease virus
03/19/1998CA2280037A1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof
03/19/1998CA2265933A1 Sustained delivery device and methods of making and using the same
03/19/1998CA2265927A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998CA2265925A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids
03/19/1998CA2265887A1 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
1 ... 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 ... 1823